How many stocks are there of Li Kang Biomedical Co?
The current number of stocks of Li Kang Biomedical Co is 26.96 M undefined.
In 2024, Li Kang Biomedical Co had 26.96 M outstanding stocks, a -4.08% change from the 28.11 M stocks in the previous year.
YEAR | NUMBER OF STOCKS (undefined TWD) |
---|---|
2023 | 26.96 |
2022 | 28.11 |
2021 | 28.06 |
2020 | 28.12 |
2019 | 28.1 |
2018 | 28.11 |
2017 | 28.09 |
2016 | 28.03 |
2015 | 27.97 |
2014 | 18.45 |
2013 | 6.98 |
2012 | 6.98 |
2011 | 5.36 |
2010 | 3.59 |
2009 | 2.57 |
2008 | 2.57 |
2007 | 2.03 |
2006 | 1.54 |
2005 | 1.54 |
2004 | 1.4 |
Li Kang Biomedical Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Tracking the changes in Li Kang Biomedical Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
For investors, understanding Li Kang Biomedical Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Variances in Li Kang Biomedical Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
The current number of stocks of Li Kang Biomedical Co is 26.96 M undefined.
The outstanding shares (or issued shares) of Li Kang Biomedical Co are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
The number of shares of Li Kang Biomedical Co has increased by -4.08% gesunken compared to last year.
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
There are various factors that can lead to a change. Li Kang Biomedical Co as a company can issue new shares, carry out stock splits or reverse splits.
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Over the past 12 months, Li Kang Biomedical Co paid a dividend of 1.74 TWD . This corresponds to a dividend yield of about 3.42 %. For the coming 12 months, Li Kang Biomedical Co is expected to pay a dividend of 1.74 TWD.
The current dividend yield of Li Kang Biomedical Co is 3.42 %.
Li Kang Biomedical Co pays a quarterly dividend. This is distributed in the months of .
Li Kang Biomedical Co paid dividends every year for the past 2 years.
For the upcoming 12 months, dividends amounting to 1.74 TWD are expected. This corresponds to a dividend yield of 3.42 %.
Li Kang Biomedical Co is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of Li Kang Biomedical Co from 7/26/2024 amounting to 2.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/20/2024.
The last dividend was paid out on 7/26/2024.
In the year 2023, Li Kang Biomedical Co distributed 1.242 TWD as dividends.
The dividends of Li Kang Biomedical Co are distributed in TWD.
Our stock analysis for Li Kang Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Li Kang Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.